Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $18.65 million. The enterprise value is $5.37 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 16.08 million shares outstanding. The number of shares has increased by 794.78% in one year.
| Current Share Class | 16.08M |
| Shares Outstanding | 16.08M |
| Shares Change (YoY) | +794.78% |
| Shares Change (QoQ) | +8.32% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 8.03% |
| Float | 16.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.29 |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.13 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.14 |
Financial Efficiency
Return on equity (ROE) is -103.80% and return on invested capital (ROIC) is -64.60%.
| Return on Equity (ROE) | -103.80% |
| Return on Assets (ROA) | -38.52% |
| Return on Invested Capital (ROIC) | -64.60% |
| Return on Capital Employed (ROCE) | -128.26% |
| Weighted Average Cost of Capital (WACC) | 4.72% |
| Revenue Per Employee | $45,714 |
| Profits Per Employee | -$1.60M |
| Employee Count | 7 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.46% in the last 52 weeks. The beta is 0.01, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +27.46% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 54.75 |
| Average Volume (20 Days) | 179,103 |
Short Selling Information
The latest short interest is 289,475, so 1.80% of the outstanding shares have been sold short.
| Short Interest | 289,475 |
| Short Previous Month | 227,623 |
| Short % of Shares Out | 1.80% |
| Short % of Float | 1.80% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, ALLR had revenue of $320,000 and -$11.23 million in losses. Loss per share was -$0.78.
| Revenue | 320,000 |
| Gross Profit | 320,000 |
| Operating Income | -12.61M |
| Pretax Income | -11.23M |
| Net Income | -11.23M |
| EBITDA | -12.60M |
| EBIT | -12.61M |
| Loss Per Share | -$0.78 |
Full Income StatementBalance Sheet
The company has $14.69 million in cash and $1.40 million in debt, with a net cash position of $13.29 million or $0.83 per share.
| Cash & Cash Equivalents | 14.69M |
| Total Debt | 1.40M |
| Net Cash | 13.29M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 9.83M |
| Book Value Per Share | 0.61 |
| Working Capital | 9.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.82 million and capital expenditures -$8,000, giving a free cash flow of -$14.83 million.
| Operating Cash Flow | -14.82M |
| Capital Expenditures | -8,000 |
| Depreciation & Amortization | 9,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -14.83M |
| FCF Per Share | -$0.92 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -3,939.06% |
| Pretax Margin | -3,509.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -794.78% |
| Shareholder Yield | -794.78% |
| Earnings Yield | -60.21% |
| FCF Yield | -79.49% |
Analyst Forecast
The average price target for ALLR is $9.50, which is 718.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.50 |
| Price Target Difference | 718.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 11, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
